Chimerix Inc (NASDAQ:CMRX)
| 1.38 Delayed Data As of Jun 08 |  -0.07 / -4.83%Today’s Change | 1.09 Today|||52-Week Range 2.90 | -26.08% Year-to-Date |
Latest CMRX News | Press Releases
No recent news for Chimerix Inc.
Today’s Trading
| Previous close | 1.45 |
| Today’s open | 1.46 |
| Day’s range | 1.36 - 1.46 |
| Volume | 1,313,723 |
| Average volume (3 months) | 903,168 |
| Market cap | $128.4M |
Data as of 3:59pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -149.93% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,609.15% |
| P/E ratio | 0.7 |
| Price/Sales | 4.88 |
| Price/Book | 0.50 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LIFEaTyr Pharma Inc | -0.04 | -1.74% |
| ACHVAchieve Life Science... | -0.09 | -1.50% |
| AQSTAquestive Therapeuti... | -0.02 | -0.92% |
| GOSSGossamer Bio Inc | +0.05 | +4.13% |
Data as of 3:59pm ET, 06/08/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $33.8M |
| Annual profit (last year) | $172.2M |
| Net profit margin | 509.01% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
